Авторы

  • Шукурхужаева Д.Н.

Ключевые слова:

лептин; беременность; перинатальные исходы; синдром ограничения роста плода; плацента; транспортеры; клеточная сигнализация

Библиографические ссылки

Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction onbrain structure and neurodevelopmental outcome. J Physiol 2016; 594: 807–823.

Francis JH, Permezel M, Davey MA. Perinatal mortality by birthweight centile.Aust N Z J Obstet Gynecol 2014; 54: 354–359.

Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growthamong children who have coronary events as adults. N Engl J Med 2005; 353:1802–1809.

Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, KhongTY, Silver RM, Smith GC, Boyle FM, Lawn JE, Blencowe H, Leisher SH, Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C, Wallace E, Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Frøen JF, Goldenberg RL, Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths In High-IncomeCountries Investigator Group. Stillbirths: recall to action in high-income countries.Lancet 2016; 387: 691–702.

Elliott J.A. The effect of pregnancy on the control of lipolysis in fat cells isolated from human adipose tissue. Eur. J. Clin. Investig. 1975; 5:159–163. doi: 10.1111/j.1365-2362. 1975. tb 02282. x.6.Butte N.F. Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am. J. Clin. Nutr. 2000; 71:1256S–1261S. doi: 10.1093/ajcn/71.5.1256s.

Zeng Z., Liu F., Li S. Metabolic Adaptations in Pregnancy: A Review. Ann. Nutr. Metab. 2017; 70:59–65. doi: 10.1159/000459633.

Herrera E. Lipid Metabolism in Pregnancy and Its Consequences in the Fetus and Newborn. Endocrine. 2002; 19:43–56. doi: 10.1385/ ENDO:19: 1:43.

Parrettini S., Caroli A., Torlone E. Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes. Front. Endocrinol. 2020; 11:611929. doi: 10.3389/fendo.2020.611929.

Handwerger S., Freemark M. The Roles of Placental Growth Hormone and Placental Lactogen in the Regulation of Human Fetal Growth and Development. J. Pediatr. Endocrinol. Metab. 2000; 13:343–356. doi: 10.1515/JPEM.2000.13.4.343.

Sovio U, White IR, Dacey A, Pasupathy D, Smith GCS. Screening for fetal growthrestriction with universal third-trimester ultrasonography in nulliparous women inthe Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet2015; 386: 2089–2097.

Moraitis AA, Wood AM, Fleming M, Smith GC. Birth weight percentile and therisk of term perinatal death. Obstet Gynecol 2014; 124: 274–283.

Vasak B, Koenen SV, Koster MP, Hukkelhoven CW, Franx A, Hanson MA, VisserGH. Human fetal growth is constrained below optimal for perinatal survival. Ultrasound Obstet Gynecol 2015; 45: 162–167.

McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidityand mortality among newborn infants. N Engl J Med 1999; 340: 1234–1238.15. Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetalrisk factors for stillbirth: population-based study. BMJ 2013; 346: f108.

Nogues, P.; Dos Santos, E.; Jammes, H.; Berveiller, P.; Arnould, L.; Vialard, F.; Dieudonné, M.N. Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta. Clin. Epigenetics 2019, 11, 20.

Iliodromiti S, Mackay DF, Smith GC, Pell JP, Sattar N, Lawlor DA, Nelson SM.Customised and Noncustomised Birth Weight Centiles and Prediction of Stillbirthand Infant Mortality and Morbidity: A Cohort Study of 979,912 Term SingletonPregnancies in Scotland. PLoS Med 2017; 14: e1002228.

Royston P, Altman DG. Design and analysis of longitudinal studies of fetal size.Ultrasound Obstet Gynecol 1995; 6: 307–312.

Deter RL, Lee W, Yeo L, Erez O, Ramamurthy U, Naik M, Romero R. Individualizedgrowth assessment: conceptual framework and practical implementation for theevaluation of fetal growth and neonatal growth outcome. Am J Obstet Gynecol2018; 218: S656–678.

MacDonald TM, Hui L, Tong S, Robinson AJ, Dane KM, Middleton AL, WalkerSP. Reduced growth velocity across the third trimester is associated with placentalinsufficiency in fetuses born at a normal birthweight: a prospective cohort study.BMC Med 2017; 15: 164.

Levytska K, Higgins M, Keating S, Melamed N, Walker M, Sebire NJ, Kingdom JC.Placental Pathology in Relation to Uterine Artery Doppler Findings in Pregnancieswith Severe Intrauterine Growth Restriction and Abnormal Umbilical ArteryDoppler Changes. Am J Perinatol 2017; 34: 451–457.

Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiologicalconsequences of conversion of the maternal spiral arteries for uteroplacental bloodflow during human pregnancy. Placenta 2009; 30: 473–482.

Richardson BS, Bocking AD. Metabolic and circulatory adaptations to chronichypoxia in the fetus. Comp Biochem Physiol A Mol Integr Physiol 1998; 119:717–723.

Schoots, M.H.; Bourgonje, M.F.; Bourgonje, A.R.; Prins, J.R.; van Hoorn, E.G.M.; Abdulle, A.E.; Muller Kobold, A.C.; van der Heide, M.; Hillebrands, J.-L.; van Goor, H.; et al. Oxidative stress biomarkers in fetal growth restriction with and without preeclampsia. Placenta 2021, 115, 87–96.

Stefaniak, M.; Dmoch-Gajzlerska, E. Maternal Serum and Cord Blood Leptin Concentrations at Delivery in Normal Pregnancies and in Pregnancies Complicated by Intrauterine Growth Restriction. Obes. Facts 2022, 15, 62–69.

Maymó, J.L.; Pérez Pérez, A.; Gambino, Y.; Calvo, J.C.; Sánchez-Margalet, V.; Varone, C.L. Review: Leptin gene expression in the placenta—Regulation of a key hormone in trophoblast proliferation and survival. Placenta 2011, 32 (Suppl. S2), S146–S153.

Turan S, Turan OM, Berg C, Moyano D, Bhide A, Bower S, Thilaganathan B,Gembruch U, Nicolaides K, Harman C, Baschat AA. Computerised fetal heartrate analysis, Doppler ultrasound and biophysical profile score in the prediction ofacid-base status of growth-restricted fetuses. Ultrasound Obstet Gynecol 2007; 30:750–756.

Nageotte MP, Towers CV, Asrat T, Freeman RK. Perinatal outcome with themodified biophysical profile. Am J Obstet Gynecol 1994; 170: 1672–1676.

Baschat AA. Planning, management, and delivery of the growth-restricted fetus. BestPract Res Clin Obstet Gynaecol 2018; 49: 53–65.

Whigham CA, MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu’u-LinoTJ. The untapped potential of placenta-enriched molecules for diagnostic andtherapeutic development. Placenta 2019; 84: 28–31.

Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis.BMC Pregnancy Childbirth 2015; 15: 191.

Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, Smith GC, Kingdom JC. Placental size and the prediction of severe early-onset intrauterinegrowth restriction in women with low pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol 2009; 34: 274–282.

Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S.Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016; 374: 13–22.

Shang, M.; Wen, Z. Increased placental IGF-1/mTOR activity in macrosomia born to women with gestational diabetes. Diabetes Res. Clin. Pract. 2018, 146, 211–219.

Chen, Y.-Y.; Rosario, F.J.; Abu Shehab, M.; Powell, T.L.; Gupta, M.B.; Jansson, T. Increased ubiquitination and reduced plasma membrane trafficking of placental amino acid transporter SNAT-2 in human IUGR. Clin. Sci. 2015, 129, 1131–1141.

Kwiatkowski S, Bednarek-J¸edrzejek M, Ksel J, Tousty P, Kwiatkowska E, Cymbaluk A, Rzepka R, Chudecka-Głaz A, Doł¸egowska B, Torb`e A. sFlt-1/PlGFand Doppler ultrasound parameters in SGA pregnancies with confirmed neonatalbirth weight below 10th percentile. Pregnancy Hypertens 2018; 14: 79–85.

Herraiz I, Quezada MS, Rodriguez-Calvo J, Gómez-Montes E, Villala´ın C, Galindo A. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy withearly-onset fetal growth restriction. Ultrasound Obstet Gynecol 2018; 52: 631–638.

Balachandiran, M.; Bobby, Z.; Dorairajan, G.; Gladwin, V.; Vinayagam, V.; Packirisamy, R.M. Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth. Placenta 2021, 104, 71–80.

Crimmins S, Desai A, Block-Abraham D, Berg C, Gembruch U, Baschat AA. Acomparison of Doppler and biophysical findings between liveborn and stillborngrowth-restricted fetuses. Am J Obstet Gynecol 2014; 211: 669.e1–10.

Savchev S, Figueras F, Sanz-Cortes M, Cruz-Lemini M, Triunfo S, Botet F, Gratacos E. Evaluation of an optimal gestational age cut-off for the definition ofearly- and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36: 99–105.